ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 230,72
1,47%
Dow Jones
43 753,99
-0,20%
DAX
23 186,86
3,07%
Brent Oil
72,565
-0,87%
Bitcoin
89 829,78
-4,69%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. TFF Pharmaceuticals Inc (TFFP)

  7. TFF Pharmaceuticals Inc (TFFP) Actualités

TFFP

TFF Pharmaceuticals (TFFP)

TFF Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TFFP
DateHeureSourceTitreSymboleSociété
06/02/202522h05PR Newswire (US)TFF Pharmaceuticals Announces Delisting from Nasdaq and Potential SEC DeregistrationNASDAQ:TFFPTFF Pharmaceuticals Inc
04/02/202522h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TFFPTFF Pharmaceuticals Inc
03/02/202522h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TFFPTFF Pharmaceuticals Inc
23/12/202412h50Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
11/12/202422h05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TFFPTFF Pharmaceuticals Inc
20/11/202423h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TFFPTFF Pharmaceuticals Inc
14/11/202422h20Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:TFFPTFF Pharmaceuticals Inc
14/11/202422h15GlobeNewswire Inc.TFF Pharmaceuticals Announces It Will Wind Down OperationsNASDAQ:TFFPTFF Pharmaceuticals Inc
26/09/202413h00GlobeNewswire Inc.TFF Pharmaceuticals’ Technology Generates Superior Inhalational Dry Powder Formulations for Pulmonary Drug DeliveryNASDAQ:TFFPTFF Pharmaceuticals Inc
11/09/202413h00GlobeNewswire Inc.TFF Pharmaceuticals Partners with Emory University and BARDA to Develop a Dry Powder Inhaled mRNA-based Treatment for Influenza and COVIDNASDAQ:TFFPTFF Pharmaceuticals Inc
10/09/202413h00GlobeNewswire Inc.TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal ImmunizationNASDAQ:TFFPTFF Pharmaceuticals Inc
03/09/202414h00GlobeNewswire Inc.TFF Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:TFFPTFF Pharmaceuticals Inc
14/08/202422h05GlobeNewswire Inc.TFF Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:TFFPTFF Pharmaceuticals Inc
08/07/202423h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
14/06/202422h05Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TFFPTFF Pharmaceuticals Inc
17/05/202422h07Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TFFPTFF Pharmaceuticals Inc
07/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TFFPTFF Pharmaceuticals Inc
08/12/202322h52Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TFFPTFF Pharmaceuticals Inc
04/12/202323h25Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TFFPTFF Pharmaceuticals Inc
21/11/202322h41Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TFFPTFF Pharmaceuticals Inc
04/10/202322h10Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TFFPTFF Pharmaceuticals Inc
17/08/202322h01GlobeNewswire Inc.TFF Pharmaceuticals Announces Closing of $5.7 Million Public Offering of Common Stock, Including Full Exercise of Over-Allotment OptionNASDAQ:TFFPTFF Pharmaceuticals Inc
15/08/202312h00GlobeNewswire Inc.TFF Pharmaceuticals Prices $5 Million Public Offering of Common StockNASDAQ:TFFPTFF Pharmaceuticals Inc
27/06/202312h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TFFPTFF Pharmaceuticals Inc
23/06/202323h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TFFPTFF Pharmaceuticals Inc
11/05/202322h08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/03/202321h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TFFPTFF Pharmaceuticals Inc
13/02/202322h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TFFPTFF Pharmaceuticals Inc
27/12/202215h28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
15/12/202223h02Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:TFFPTFF Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:TFFP

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
EU
EN
Bouygues
SPI
SP500
S&P 500
EU
BEL20
Bel 20
NASDAQ
AAPL
Apple
EU
BN
Danone
EU
LR
Legrand
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
COIN
AVAXUSD
Avalanche
EU
MC
Lvmh Moet Hennessy Louis...
EU
RNO
Renault
NYSE
NKE
Nike
FTSE
UKX
FTSE 100
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces